Truveta news For media inquiries, please email news@truveta.com Truveta Language Model unlocks EHR data for the most complete and accurate medical research April 12, 2023 Partnership announced between Truveta and Alpine Immune Sciences March 22, 2023 Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being… New SDOH data in Truveta Studio March 1, 2023 LinkedIn Live: Truveta Research discusses recent maternal heart health study February 15, 2023 The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color… Truveta partners honored as Modern Healthcare’s 100 Most Influential December 7, 2022 We’re proud to share that leaders from a number of our health system members have been named as Modern Healthcare’s 100 Most Influential People In Healthcare… Truveta Research presents at the 150th Annual APHA November 18, 2022 Last week, two members of Truveta Research — Dr. Charlotte Baker, DrPH, MPH, CPH, and Dr. Peter Smits, PhD — attended the 150th Annual Meeting of… Introducing Truveta Studio, the first health data and analytics solution to study patient care and patient outcomes November 2, 2022  In just over two years — with amazing teamwork across Truveta and our 25 health system members, and strategic partnerships with customers like Pfizer and… Welcome HonorHealth to Truveta October 17, 2022 Today we are honored to welcome our 25th health system member — HonorHealth — to Truveta. Truveta was formed and is governed by US health systems… « Previous 1 … 8 9 10 11 Next » Truveta in the news Children who miss early vaccines more likely to not get the MMR shot by age 2 Women with PCOS seek relief in weight-loss drugs Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says FDA to streamline approvals for generic biological drugs in latest move targeting health costs See all articles Recent press releases Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics December 5, 2023 Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors December 4, 2023 Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss November 27, 2023 Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research November 8, 2023 See all press releases Images Truveta logo Format: PNG Truveta Data Map Format: PNG Truveta Health System Members Format: PNG
Truveta Language Model unlocks EHR data for the most complete and accurate medical research April 12, 2023
Partnership announced between Truveta and Alpine Immune Sciences March 22, 2023 Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being…
LinkedIn Live: Truveta Research discusses recent maternal heart health study February 15, 2023 The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color…
Truveta partners honored as Modern Healthcare’s 100 Most Influential December 7, 2022 We’re proud to share that leaders from a number of our health system members have been named as Modern Healthcare’s 100 Most Influential People In Healthcare…
Truveta Research presents at the 150th Annual APHA November 18, 2022 Last week, two members of Truveta Research — Dr. Charlotte Baker, DrPH, MPH, CPH, and Dr. Peter Smits, PhD — attended the 150th Annual Meeting of…
Introducing Truveta Studio, the first health data and analytics solution to study patient care and patient outcomes November 2, 2022  In just over two years — with amazing teamwork across Truveta and our 25 health system members, and strategic partnerships with customers like Pfizer and…
Welcome HonorHealth to Truveta October 17, 2022 Today we are honored to welcome our 25th health system member — HonorHealth — to Truveta. Truveta was formed and is governed by US health systems…
Truveta Research on increased speech delays in children during the pandemic published in JAMA Pediatrics December 5, 2023
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors December 4, 2023
Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss November 27, 2023
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research November 8, 2023